ArticleNutrition & metabolism2024
Deciphering the role of oleic acid in diabetic retinopathy: an empirical analysis of monounsaturated fatty acids.
Article in Nutrition & metabolism, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- Do oleic acid-enriched oil formulations improve health outcomes in metabolic disorders? A GRADE-assessed meta-analysis.Frontiers in nutrition · 2026Pooled it
- Mediterranean diet and diabetic microvascular complications: a systematic review and meta-analysis.BMC nutrition · 2025Pooled it
- Integrative Analysis of Volatile Flavor Compounds and Transcriptome Reveals Underlying Mechanisms Linked to Fatty Acid Content in Dabieshan Cattle.Foods (Basel, Switzerland) · 2026Article
- Associations of abdominal obesity and plasma fatty acids with microvascular diseases.Communications medicine · 2026Article
- GC-MS metabolomic profiling and PPARγ-targetedFrontiers in nutrition · 2026Article
- Ferroptosis in diabetic retinopathy: from pathogenic mechanisms to translational prospects.Frontiers in endocrinology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
aimsThe existing literature indicates that oleic acid (OA) is the most prevalent monounsaturated fatty acid (MUFA) in both diet and plasma, known for its beneficial impact on insulin resistance and inflammation. However, its role in diabetic retinopathy (DR) remains unclear. This study aims to elucidate the association between OA and DR and explore its potential in DR detection.
methodsWe conducted a two-center, propensity score-matched case-control study, including 69 type 2 diabetes (T2D) patients with diagnosed DR (cases) and 69 matched T2D individuals without DR (control), in China from August 2017 to June 2018. Multiple logistic regression models analyzed the association between MUFAs and DR. The impact of 7 distinct MUFAs on DR was examined using elastic net regression (ENET), weighted quantile regression (WQS), and Bayesian kernel machine regression (BKMR), focusing on key lipid biomarkers. The diagnostic utility of these biomarkers was assessed by calculating the AUC.
resultsA significant negative correlation was found between MUFAs and DR, with OA identified as pivotal by ENET, WQS, and BKMR. The adjusted OR and 95% CI for DR were 0.25 (0.09, 0.69) for subjects in the 2nd tertile of OA and 0.11 (0.04, 0.30) for the 3rd tertile, compared to the lowest tertile. These results were consistent across subgroup and sensitivity analyses. The AUC (95% CI) for OA alone was 0.72 (0.63, 0.81), increasing to 0.77 (0.69, 0.85) when combined with other covariates.
conclusionsOur findings reveal a robust inverse relationship between plasma OA levels and DR risk, suggesting that OA could serve as a valuable biomarker for identifying type 2 diabetic patients with DR.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.